Clinical trials
Completed Phase 2 Leukemia, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| German CLL Study Group | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| King's College Hospital NHS Trust | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Novartis Pharmaceuticals | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Pharmacyclics LLC. | 1 |
| Polish Lymphoma Research Group | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 20 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Lymphoma, B-Cell | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia | 2 |
| Leukemia, Lymphoid | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.